The Challenging Treatment of Cisplatin-Resistant Tumors: State of the Art and Future Perspectives
One of the main problems in chemotherapy using platinum drugs as anticancer agents is the resistance phenomenon. Synthesizing and evaluating valid alternative compounds is challenging. This review focuses on the last two years of progress in the studies of platinum (II)- and platinum (IV)-based anti...
Main Authors: | Giulia Coffetti, Martina Moraschi, Giorgio Facchetti, Isabella Rimoldi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/8/3407 |
Similar Items
-
Oxidation of the Platinum(II) Anticancer Agent [Pt{(<i>p</i>-BrC<sub>6</sub>F<sub>4</sub>)NCH<sub>2</sub>CH<sub>2</sub>NEt<sub>2</sub>}Cl(py)] to Platinum(IV) Complexes by Hydrogen Peroxide
by: Ruchika Ojha, et al.
Published: (2023-09-01) -
Platinum(IV)-Loaded Degraded Glycol Chitosan as Efficient Platinum(IV) Drug Delivery Platform
by: Yvonne Lerchbammer-Kreith, et al.
Published: (2023-03-01) -
Combination of Drug Delivery Properties of PAMAM Dendrimers and Cytotoxicity of Platinum(IV) Complexes—A More Selective Anticancer Treatment?
by: Yvonne Lerchbammer-Kreith, et al.
Published: (2023-05-01) -
Platinum and Palladium Complexes as Promising Sources for Antitumor Treatments
by: Robert Czarnomysy, et al.
Published: (2021-07-01) -
Reactions with Proteins of Three Novel Anticancer Platinum(II) Complexes Bearing N-Heterocyclic Ligands
by: Francesca Sacco, et al.
Published: (2021-09-01)